Compugen Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Compugen (CGEN) PT Lowered to $14 at Truist Securities
February 25, 2022 6:36 AM ESTTruist Securities analyst Asthika Goonewardene lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Following the EPS call and our discussion with mgmt, we are adjusting our model to reflect a slower route... More
Compugen (CGEN) PT Lowered to $14 at Stifel
February 24, 2022 12:17 PM ESTStifel analyst Stephen Willey lowered the price target on Compugen (NASDAQ: CGEN) to $14.00 (from $20.00) while maintaining a Buy rating.
The analyst commented, "Management continues to make progress on the various dose expansion cohorts comprising the P1/2 development program evaluating various COM701-based combinations... More
